IndraLab

Statements


Hydroxychloroquine inhibits toll-like receptors TLRs. 1 / 1
| 1

eidos
"Interestingly , hydroxychloroquine ( Plaquenil ) , an antimalarial drug , has also been reported to downregulate the expression of toll-like receptors ( TLRs ) and IL-6 production , and therefore may have potential anti-COVID-19 activity [ supplementary materials 3 ] ."